POST DOCS

Rolf Bekendam, MD, PhD

3 Blackfan Circle, Room 924
Boston, MA 02115
rbekenda@bidmc.harvard.edu

Rolf is originally from the Netherlands where he received his Medical degree from the University of Groningen. He initially joined as a medical student and was able to continue his research at BIDMC in collaboration with the Aix-Marseille University (France), at which he is currently enrolled in a PhD program. His research has been focused around the development of novel protein disulfide isomerase (PDI) inhibitors using high throughput screening. He is currently conducting research to identify crucial endogenous mediators of PDI inhibition.

Awards:

2015 – Young Investigator Award – International Society on Thrombosis and Haemostasis
2016 – Young Investigator Award – International Society on Thrombosis and Haemostasis

Maneli Doroudian, MD

3 Blackfan Circle, Room 924
Boston, MA 02115
mdoroudi@bidmc.harvard.edu
 

Maneli is a postdoctoral research fellow who joined the Flaumenhaft lab in 2018, to study the critical role of the endothelial Angiopoietin-Tie2 pathway in thrombosis. She grew up in Tehran then moved to Boston, after completing her medical school and working as a physician for a couple of years. Outside of the lab, Maneli is a nature and art enthusiast, enjoys spending time with family and friends, along with traveling.

Keiichi Enjoji, PhD

3 Blackfan Circle, Room 924
Boston, MA 02115
kenjoji@bidmc.harvard.edu
 

Keiichi obtained his Ph.D from Kyushu University in Japan in biochemistry. His research is focused on analyzing the role of intrinsic coagulation pathway on stroke using mice model. Previously he worked on the role of cd39/ENTPDase1 in metabolic disease such as atherosclerosis and diabetes and in inflammation at BIDMC.

Shihui Guo, PhD

3 Blackfan Circle, Room 924
Boston, MA 02115
sguo3@bidmc.harvard.edu
 

Dr. Shihui is a postdoctoral fellow in the Division of Hemostasis and Thrombosis. He attended School of Life Sciences at the Fujian Agriculture and Forestry University and obtained his Master of Science degree in Biochemical and Molecular biology from Fujian Institute of Research on the Structure of Matter, Chinese Academy of Sciences. He completed a FWF doctoral fellowship Program at the University of Salzburg and continued Postdoc training at the BIDMC Harvard Medical School with a CSC Scholarship. He is currently working on protein disulfide isomerase (PDI) to evaluate the molecular mechanisms underlying the regulatory function of PDI in thrombus formation.  A thorough biophysical and biochemical evaluation will enable a better understanding of the pathophysiology and novel approaches on prevention and treatment of thrombotic diseases.

Lin Lin, PhD

Glenn Merrill-Skoloff, B.S.

Glenn is a New England native having been born and raised in Pigeon Cove, Massachusetts. In 1993, he recived a Bachelor of Science degree in Biochemistry from the University of Massachusetts at Amherst. He joined the Division of Hemostasis and Thrombosis at New England Medical Center in 1995, migrating to the Beth Israel Deaconess Medical Center when the division relocated in 1999. Since moving to BIDMC, his focus has been studying thrombosis using intravital microscopy and a laser ablation injury model in the cremaster muscle of mice. This technique was developed, in part, by Glenn who is currently the Director of the Intravital Microscopy Core Facility as well as the Laboratory Manager for the division.

Oluwatoyosi Muse, PhD

3 Blackfan Circle, Room 924
Boston, MA 02115
omuse@bidmc.harvard.edu
 

Oluwatoyosi graduated from Binghamton University with her PhD in Chemistry. Her research is focused on evaluating the effects of protein disulfide inhibitors on platelet function and thrombin generation in clinical samples from patients with solid tumors and myeloproliferative neoplasm.

Awards:

2019 Mary Rodes Gibson Memorial Award in Hemostasis and Thrombosis

Justine Ryu, MD

 3 Blackfan Circle, Room 924
Boston, MA 02115
jryu1@bidmc.harvard.edu
 

Justine is a research fellow who joined the Bendapudi Lab under T-32 training program to define and characterize the underlying genetic mechanism of purpura fulminans. She received her M.D. at Boston University School of Medicine and completed her internal medicine residency at Boston Medical Center. Her research aims to advance the understanding and management of hematologic disorders applying genetic sequencing and basic molecular research. Outside of the lab she enjoys spending time with family and friends, eating anything made from carbohydrates and cheese, reading, and traveling.

Alec Schmaier, MD, PhD

3 Blackfan Circle, Room 924
Boston, MA 02115
aschmaie@bidmc.harvard.edu
 

Alec A. Schmaier is an Instructor of Medicine at Harvard Medical School and Cardiologist and
Vascular Medicine physician at Beth Israel Deaconess Medical Center. He completed his
MD/PhD at the University of Pennsylvania, working in the laboratory of Mark Kahn, where he
studied collagen-induced platelet activation.

In collaboration with the Samir Parikh laboratory, Dr Schmaier’s research focuses and
endothelial modulation by the Tie2-Angiopoietin pathway. Specific projects include control of
Tie2 signaling using optogenetic approaches and the role platelet-derived angiopoietin-1 in
sepsis, thrombosis, and tumor metastasis. Working along with Sol Schulman, Dr. Schmaier is
characterizing novel regulators of endothelial-mediated thrombosis. His research is funded by
the Hemostasis and Thrombosis Research Society and the John S. LaDue Memorial Fellowship
at Harvard Medical School. He maintains a clinical practice in general cardiology and vascular
medicine, where he focuses on thrombotic disorders and vasculitis. When he is not at work, he
is busy with his two daughters, and wishing he more time to play tennis and guitar.

Zach Schoepflin, MD, PhD

3 Blackfan Circle, Room 924
Boston, MA 02115
zschoepf@bidmc.harvard.edu
 

Zach graduated from Thomas Jefferson University with his MD and PhD in cell biology and regenerative medicine. He is currently a resident in internal medicine at BIDMC. His research in the Schulman lab is focused on using high-throughput approaches to identify FDA-approved compounds that have off-target effects on tissue factor activity.

Moua Yang, PhD

3 Blackfan Circle, Room 924
Boston, MA 02115
myang4@bidmc.harvard.edu
 

Moua obtained his Ph.D. in Cell Biology from the Medical College of Wisconsin where his training was performed at the Blood Research Institute of Versiti Blood Center of Wisconsin. He joined the Flaumenhaft lab under the support of the T-32 training program. Moua‘s research focus will be on understanding thiol isomerases in thrombosis and hemostasis. Additionally, he will study the dynamics of in vivo thrombus formation in murine models. He likes outdoor activities, including fishing and hiking, and hanging out with friends.

Alumni Post-Docs

David A. Barrios, PhD

 
David is a native of Chicago and is an avid fan of both the Cubs and Red Sox. After serving honorably in the U.S. Navy, David went on to receive his B.S. in Chemistry from the University of Illinois at Urbana-Champaign in 2008 and his Ph.D. in Chemistry from North Carolina State in 2013. His research in this lab focused on lateral flow assay development for screening the efficacy of antiplatelet therapies as well as exploring the role of PDI in hemostasis and thrombosis.

Karen De Ceunynck, PhD

 

Karen is originally from Belgium where she received her Master’s degrees in Biomedical Sciences and Molecular Biotechnology from Ghent University and her PhD in Biochemistry & Biotechnology from the Catholic University of Leuven. Her research has been focused on understanding processes involved in hemostasis and thrombosis and using that knowledge to guide the development of novel therapeutics. She previously worked on conducting translation research to evaluate how endothelial therapies can reduce uncontrolled blood clotting in the setting of infectious disease. ​

Awards:

2015 – Young Investigator Award – International Society on Thrombosis and Haemostasis
2016 to Present – NIH T32 Training Grant
2016 – Translational Research Training in Hematology (TRTH) – Joint EHA and ASH award
2016 – Abstract Achievement Award – American Society of Hematology (ASH)
2017 – Young Investigator Award – International Society on Thrombosis and Haemostasis

Oskar Eriksson, MD, PhD

 

Oskar received his MD and PhD from the University of Uppsala in Sweden. His PhD thesis focused on experimental and translational studies on cell signaling by coagulation proteases in the context of cancer. Oskar joined the lab in 2016 and worked on understanding the role of extracellular thiol isomerases in the initiation of plasma cascade systems during thromboinflammation.

Awards:

2016 to 2018 – International Post Doctoral Fellowship – Swedish Research Council

Sarah Higgins, PhD

 

Sarah was previously a postdoctoral research fellow who joined the Flaumenhaft lab to study the critical role of the endothelial angiopoietin-Tie2 pathway in thrombosis, as an extension of the collaborative partnership between the Division of Thrombosis and Hemostasis and Center for Vascular Biology Research at BIDMC. Overall, Sarah’s work aimed to apply basic molecular research to tackle unmet global health needs, with a specific focus on vascular biology in the setting of infection, thrombosis and inflammation. Sarah received her B.Sc. in Forensic Science from Trent University and PhD in Laboratory Medicine from the University of Toronto where her work at the Sandra Rotman Centre for Global Health led to a patented host-targeted treatment intervention for cerebral malaria developed in collaboration with industry partners. Outside the lab, Sarah is an avid runner and nature enthusiast who can often be found exploring NE’s many incredible mountains and craft breweries.

Awards:

Frederick Banting and Charles Best Canada Graduate Scholarships CIHR Doctoral Award
2016 – 2018 – American Heart Association Postdoctoral Research Fellowship Founders Affiliate Award

Christian Peters, PhD

 

Christian received his Bachelor of Science at Bethany College in West Virginia.  Afterwards he received his Master’s degree at the Indiana University of Pennsylvania and his PhD in Biomedical Sciences from the University of Toledo.  His research interests have been focused on the cellular and molecular basis of peptide and protein secretion.  He conducted research in this lab to demonstrate the movement of distinct populations of alpha-granules in platelets.  Additionally, a portion of his research was focused on endothelial responses to various small molecules.

Jack Stopa, PhD

 

Noppacharn Uaprasert, MD

 

Noppacharn is originally from Bangkok, Thailand. He received Doctor of Medicine and certified Board of Hematology from Chulalongkorn University. He is a faculty member at Division of Hematology, Department of Medicine, Faculty of Medicine, Chulalongkorn University. He received a two-year scholarship from Anandamahidol Foundation between 2016-2018 to study in advanced basic science research. His research was focused on thalassemia and hemoglobinopathies as well as hemostasis and thrombosis. His research in this lab were focused on mechanisms of protein disulfide isomerase in regulation of platelet functions and hemostasis and thrombosis models in mice with hemostatic defects.

Awards:

2017 – Abstract Achievement Award – American Society of Hematology (ASH)